サマリー

世界のウイルスベクター市場 2022-2026
Technavioはウイルスベクター市場を監視しており、2022-2026年の間に4億9064万ドルの成長が見込まれ、予測期間中にCAGR 14.23%で加速しています。当レポートでは、ウイルスベクター市場の全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、約25のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、慢性疾患の有病率の上昇、遺伝子治療やワクチン開発へのウイルスベクターの使用の増加、遺伝子治療やワクチンへの資金調達や投資の増加によって牽引されています。
ウイルスベクター市場の分析には、アプリケーションセグメントと地理的展望が含まれます。
Technavioのウイルスベクター市場は、以下のようにセグメント化されています。
アプリケーション別
- 遺伝子治療
- ワクチン
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間におけるウイルスベクター市場の成長を促進する主な理由の1つとして、ウイルスベクターを用いた遺伝子治療やワクチン開発のための研究開発活動が増加していることを挙げています。また、M&Aや共同研究の増加、ウイルスベクターを製造するための新しい技術の出現は、市場の大きな需要につながるでしょう。
Technavioは、複数のソースからのデータの研究、合成、主要パラメータの分析による総括の方法により、市場の詳細な姿を提示します。ウイルスベクター市場に関する弊社のレポートは、以下の分野を対象としています。
- ウイルスベクター市場のサイジング
- ウイルスベクター市場の予測
- ウイルスベクター市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Batavia Biosciences BV、Bayer AG、Catalent Inc、Creative Biogene、Danaher Corp.を含む複数の主要ウイルスベクター市場ベンダーについて詳細に分析し、その結果を掲載しています。F. Hoffmann La Roche Ltd., FinVector Oy, Freeline Therapeutics Holdings plc, FUJIFILM Holdings Corp, Institut Merieux, Lonza Group Ltd., Merck KGaA, Novartis AG, Oxford Biomedica Plc, REGENXBIO Inc, Sirion Biotech GmbH, Takara Holdings Inc, Thermo Fisher Scientific Inc, uniQure NVおよびVirovek Inc.などです。また、ウイルスベクター市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/viral-vector-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Application
o 5.1 Market segments
o Exhibit 24: Chart on Application - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
o 5.2 Comparison by Application
o Exhibit 26: Chart on Comparison by Application
o Exhibit 27: Data Table on Comparison by Application
o 5.3 Gene therapy - Market size and forecast 2021-2026
o Exhibit 28: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
o 5.4 Vaccines - Market size and forecast 2021-2026
o Exhibit 32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Application
o Exhibit 36: Market opportunity by Application ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 UK - Market size and forecast 2021-2026
o Exhibit 62: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Batavia Biosciences BV
o Exhibit 85: Batavia Biosciences BV - Overview
o Exhibit 86: Batavia Biosciences BV - Product / Service
o Exhibit 87: Batavia Biosciences BV - Key offerings
o 10.4 Bayer AG
o Exhibit 88: Bayer AG - Overview
o Exhibit 89: Bayer AG - Business segments
o Exhibit 90: Bayer AG - Key offerings
o Exhibit 91: Bayer AG - Segment focus
o 10.5 Creative Biogene
o Exhibit 92: Creative Biogene - Overview
o Exhibit 93: Creative Biogene - Product / Service
o Exhibit 94: Creative Biogene - Key offerings
o 10.6 F. Hoffmann La Roche Ltd.
o Exhibit 95: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 96: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 97: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 98: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 99: F. Hoffmann La Roche Ltd. - Segment focus
o 10.7 FinVector Oy
o Exhibit 100: FinVector Oy - Overview
o Exhibit 101: FinVector Oy - Product / Service
o Exhibit 102: FinVector Oy - Key offerings
o 10.8 FUJIFILM Holdings Corp
o Exhibit 103: FUJIFILM Holdings Corp - Overview
o Exhibit 104: FUJIFILM Holdings Corp - Business segments
o Exhibit 105: FUJIFILM Holdings Corp - Key offerings
o Exhibit 106: FUJIFILM Holdings Corp - Segment focus
o 10.9 Lonza Group Ltd.
o Exhibit 107: Lonza Group Ltd. - Overview
o Exhibit 108: Lonza Group Ltd. - Business segments
o Exhibit 109: Lonza Group Ltd. - Key news
o Exhibit 110: Lonza Group Ltd. - Key offerings
o Exhibit 111: Lonza Group Ltd. - Segment focus
o 10.10 Merck KGaA
o Exhibit 112: Merck KGaA - Overview
o Exhibit 113: Merck KGaA - Business segments
o Exhibit 114: Merck KGaA - Key news
o Exhibit 115: Merck KGaA - Key offerings
o Exhibit 116: Merck KGaA - Segment focus
o 10.11 Oxford Biomedica Plc
o Exhibit 117: Oxford Biomedica Plc - Overview
o Exhibit 118: Oxford Biomedica Plc - Business segments
o Exhibit 119: Oxford Biomedica Plc - Key offerings
o Exhibit 120: Oxford Biomedica Plc - Segment focus
o 10.12 Thermo Fisher Scientific Inc.
o Exhibit 121: Thermo Fisher Scientific Inc. - Overview
o Exhibit 122: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 123: Thermo Fisher Scientific Inc. - Key news
o Exhibit 124: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 125: Thermo Fisher Scientific Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Application ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Batavia Biosciences BV - Overview
Exhibits86: Batavia Biosciences BV - Product / Service
Exhibits87: Batavia Biosciences BV - Key offerings
Exhibits88: Bayer AG - Overview
Exhibits89: Bayer AG - Business segments
Exhibits90: Bayer AG - Key offerings
Exhibits91: Bayer AG - Segment focus
Exhibits92: Creative Biogene - Overview
Exhibits93: Creative Biogene - Product / Service
Exhibits94: Creative Biogene - Key offerings
Exhibits95: F. Hoffmann La Roche Ltd. - Overview
Exhibits96: F. Hoffmann La Roche Ltd. - Business segments
Exhibits97: F. Hoffmann La Roche Ltd. - Key news
Exhibits98: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits99: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits100: FinVector Oy - Overview
Exhibits101: FinVector Oy - Product / Service
Exhibits102: FinVector Oy - Key offerings
Exhibits103: FUJIFILM Holdings Corp - Overview
Exhibits104: FUJIFILM Holdings Corp - Business segments
Exhibits105: FUJIFILM Holdings Corp - Key offerings
Exhibits106: FUJIFILM Holdings Corp - Segment focus
Exhibits107: Lonza Group Ltd. - Overview
Exhibits108: Lonza Group Ltd. - Business segments
Exhibits109: Lonza Group Ltd. - Key news
Exhibits110: Lonza Group Ltd. - Key offerings
Exhibits111: Lonza Group Ltd. - Segment focus
Exhibits112: Merck KGaA - Overview
Exhibits113: Merck KGaA - Business segments
Exhibits114: Merck KGaA - Key news
Exhibits115: Merck KGaA - Key offerings
Exhibits116: Merck KGaA - Segment focus
Exhibits117: Oxford Biomedica Plc - Overview
Exhibits118: Oxford Biomedica Plc - Business segments
Exhibits119: Oxford Biomedica Plc - Key offerings
Exhibits120: Oxford Biomedica Plc - Segment focus
Exhibits121: Thermo Fisher Scientific Inc. - Overview
Exhibits122: Thermo Fisher Scientific Inc. - Business segments
Exhibits123: Thermo Fisher Scientific Inc. - Key news
Exhibits124: Thermo Fisher Scientific Inc. - Key offerings
Exhibits125: Thermo Fisher Scientific Inc. - Segment focus
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations